Insulet downgraded at Baird on concerns over insulin pump loyalty | Seeking Alpha


























Wall Street New York stock exchange stock market

alexsl

  • Baird downgraded Insulet (PODD) to Neutral from Overweight, citing a recent survey that found lower brand loyalty to automated insulin delivery (AID) systems than in the past.
  • The firm cut its price target to $158 from $200 (~19% upside based on Friday’s close).

Source link

Leave a Reply

Discover more from Occasional Digest

Subscribe now to keep reading and get access to the full archive.

Continue reading